MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2017 International Congress

    Absence of depression in de novo Parkinson’s disease: a benign motor phenotype?

    H.S. YOO, Y. Lee, J.J. Lee, S.J. Chung, P.H. Lee, Y.H. Sohn (Seoul, Republic of Korea)

    Objective: This study aimed to assess the impact of early depression on motor deficits relative to the level of striatal dopaminergic depletion in patients with…
  • 2017 International Congress

    A pilot study of mindfulness yoga on psychological distress in people with Parkinson’s Disease (PD)

    JJ.Y.-Y. Kwok, J.C.-y. Kwan, H.Y.-L. Chan (Hong Kong, Hong Kong)

    Objective: This study aimed to examine the feasibility of a mindfulness yoga programme among people with PD. Background: Psychological distress like anxiety and depression is…
  • 2017 International Congress

    Internet-based Cognitive Behavioral Therapy for general function in patients with Parkinson’s Disease: A randomized controlled trial.

    M. Kraepelien, R. Schibbye, P. Svenningsson, N. Lindefors, V. Kaldo (Stockholm, Sweden)

    Objective: This study investigates the effect of therapist-guided internet-based cognitive behavioral therapy (ICBT) for general function in Parkinson’s disease (PD) compared to a waitlist. Background:…
  • 2017 International Congress

    Differences in cerebral perfusion between Major depression disorder and depression with Parkinson’s disease : Brain HMPAO SPECT study using SPM analysis

    Y.-D. Kim, Y.-D. Kim (Incheon, Republic of Korea)

    Objective:  We performed SPECT in Major depressive (MD) disorder and PD patients with (PDMD) and without depression (PDNMD). The aim of this work was to…
  • 2017 International Congress

    Assisted Suicide of patients with parkinsonian syndromes in Switzerland – the need of early and continuous integration of palliative care and dignitiy therapy

    S. Lorenzl, L. Butzhammer, G. Nübling (Salzburg, Austria)

    Objective: To determine the prevalence of patients with parkinsonian syndromes who performed assisted suicide (AS) at DIGNITAS in Switzerland from 2006 till 2012 and to analyze…
  • 2017 International Congress

    Redefining social work for Parkinson’s: the development of a model of care for specialized support in the clinic, community and home

    A. Lemen, LCSW, M. Sweeney, LMSW, V. Luce, LCSW, D. Rayment, LMSW, A. Di Rocco (New York, NY, USA)

    Objective: The development of a dynamic, multimodal social work program model for individuals, caregivers and families living with Parkinson’s disease Background: Patients living with Parkinson’s…
  • 2017 International Congress

    Contact location and non-motor outcomes in subthalamic nucleus deep brain stimulation for Parkinson’s disease

    D. Floden, C. Matias, C. Wathen, G. Ozinga, O. Hogue, A. Machado (Cleveland, OH, USA)

    Objective: To determine whether the precise location of stimulation affects cognitive performance and mood. Background: Deep brain stimulation of the subthalamic nucleus effectively treats the…
  • 2017 International Congress

    Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression

    E. Dalle, D. William, M. Musa (Durban, South Africa)

    Objective: The objective of this study was to investigate how fluvoxamine maleate treatment regulates depressive-like symptoms, motor impairments and the expressions of IL-1beta, IL-6, IL-10…
  • 2017 International Congress

    The Huntington’s Disease Health Index Study (HD-HI)

    A. Glidden, E. Luebbe, M. Elson, S. Goldenthal, R. Dorsey, C. Heatwole (Rochester, NY, USA)

    Objective: To identify the symptomatic domains with the greatest impact on quality-of-life for those living with Huntington’s Disease (HD) through patient and caregiver interviews. Background:…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley